With potent antiretroviral therapy (ART) and simplified regimens, progression of HIV infection to acquired immunodeficiency syndrome (AIDS) may be significantly delayed or avoided, and people living with HIV are achieving near-normal lifespans. Many are suffering from HIV-associated comorbidities, coinfections, and complications (HIV-associated CCCs), however, often against a background of multiple complicating factors such as stigma, isolation, and socioeconomic challenges. Meanwhile, multiple factors likely contribute to poor health in people living with HIV, including the direct impacts of HIV on multiple organ systems, toxicity of ART, and polypharmacy. People in corrections generally face a history of poverty and poor health care prior to incarceration. This session will identify the special risks for HIV-associated CCCs for incarcerated patients living with HIV and the strategies available to prevent, control, and treat them.

Educational objectives

• Identify the most common comorbidities, coinfections, and complications that affect individuals with HIV
• Discuss how the social determinants of health and complicating factors such as stigma affect incarcerated individuals with HIV
• Describe optimal prevention and treatment for HIV for incarcerated individuals

Sponsored by an independent educational grant from Merck